1-Jahres-Chart (nicht börsennotiert)
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CIVITAS SOLUTIONS Aktie jetzt für 0€ handeln |
0 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| DEXCOM | 84,32 | +0,14 % | American Diversified Holdings Corporation: American Diversifield Holdings Corporation (ADHC) Provides Update on Dexcom/GlucoGuard App Development Through UC Irvine MADO Program | Del Mar, California--(Newsfile Corp. - February 4, 2025) - American Diversified Holdings Corporation (OTC Pink: ADHC) pleased to provide the shareholder community an update on the progress Glucoguard... ► Artikel lesen | |
| PLUS THERAPEUTICS | 1,188 | 0,00 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
| CARDINAL HEALTH | 121,25 | +0,58 % | Aktie von Cardinal Health: Kurs mit wenig Bewegung (122,6302 €) | Die Wertschätzung für das Wertpapier von Cardinal Health hat sich an der Börse heute kaum geändert. Zuletzt zahlten Investoren für das Papier 127,75 US-Dollar. Kaum auffällig ist derzeit am Aktienmarkt... ► Artikel lesen | |
| DAVITA | 170,35 | -0,29 % | DaVita: For Improving Transplant Access, Collaboration Holds the Key | DaVita's work with Kansas City-area transplant centers has helped streamline communication, create solutions to support patients. NORTHAMPTON, MA / ACCESS Newswire / February 3, 2025 / Kidney transplant... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| DENTSPLY SIRONA | 18,550 | -0,11 % | Deep Dive Into Dentsply Sirona Stock: Analyst Perspectives (8 Ratings) | ||
| CYTOSORBENTS | 0,973 | +2,10 % | CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue | Fourth quarter product revenue growth estimated at 22% to 25% year-over-year Fourth quarter gross margin estimated to improve to approximately 70% Management will host in-person investor... ► Artikel lesen | |
| CENTENE | 60,02 | +1,68 % | Centene Q4 Beats Market; Backs FY25 Earnings View, Lifts Premium And Service Revenue Forecast | WASHINGTON (dpa-AFX) - Centene Corp. (CNC), while reporting higher profit in its fourth quarter, above market estimates, on Tuesday maintained fiscal 2025 earnings view, while lifted forecast... ► Artikel lesen | |
| COOPER COMPANIES | 91,40 | -0,44 % | Jennison Associates LLC Boosts Holdings in The Cooper Companies, Inc. (NASDAQ:COO) | ||
| FULGENT GENETICS | 15,900 | +0,63 % | Fulgent Reports Third Quarter 2024 Financial Results | EL MONTE, Calif.--(BUSINESS WIRE)--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent," or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic... ► Artikel lesen | |
| EKSO BIONICS | 0,500 | -4,58 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
| IMUNON | 0,825 | -1,20 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| DELCATH SYSTEMS | 15,200 | 0,00 % | Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results | QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH) ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers... ► Artikel lesen | |
| COMMUNITY HEALTH SYSTEMS | 3,040 | 0,00 % | Stock Traders Buy Large Volume of Put Options on Community Health Systems (NYSE:CYH) | ||
| CAREDX | 22,060 | 0,00 % | CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results | BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company - today reported preliminary, unaudited financial results for the fourth quarter and full year ended December... ► Artikel lesen |
CIVITAS SOLUTIONS INC gehört der Branche Gesundheitswesen an.
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CIVITAS SOLUTIONS INC finden Sie auf Wallstreet Online.
